ATC Group: V09IX05 Fluorodopa (18F)

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V09IX05 in the ATC hierarchy

Level Code Title
1 V Various
2 V09 Diagnostic radiopharmaceuticals
3 V09I Tumour detection
4 V09IX Other diagnostic radiopharmaceuticals for tumour detection
5 V09IX05 Fluorodopa (18F)

Active ingredients in V09IX05

Active Ingredient

Fluorodopa F18 is a radioactive diagnostic agent used in PET imaging. In dopaminergic nerve terminals in the brain, fluorodopa (FDOPA) F18 is decarboxylated by amino acid decarboxylase to fluorodopamine (FDA) F18 and stored in presynaptic vesicles in the brain. The accumulation of F18 FDA in the striatum is visually detected in the PET scan.

Related product monographs

Document Type Information Source  
 DOPACIS Solution for injection MPI, EU: SmPC Medicines Authority (MT)

Medicines classified under this ATC code globally

Austria (AT)

France (FR)

Malta (MT)

Spain (ES)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.